Table 2.
MECHANISM | COMPOUNDS | CURRENT CLINICAL USE? |
---|---|---|
Inhibition of the class III PI3K (Vps34) pathway | • 3-methyladenine | |
• Wortmannin | ||
• LY294002 | ||
Impairment of AV fusion/alteration of lysosomal pH | • Chloroquine | • Antimalarial |
• Bafilomycin A1 | • Macrolide antibiotic | |
Increase of cytosolic Ca++ levels | • Thapsigargin | |
• Bay K8644 | ||
Inhibition of histone deacetylase | • Trichostatin A | |
Interaction with AMPK | • Dorsomorphin | |
• AICAR (5-aminoimidazole-4-carboxyamide ribonucleoside) |